A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)
Bristol-Myers Squibb
Bristol-Myers Squibb
CRISPR Therapeutics
Fred Hutchinson Cancer Center
Dizal Pharmaceuticals
Autolus Limited
BioInvent International AB
SymBio Pharmaceuticals
Sun Yat-sen University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Zhengzhou University
City of Hope Medical Center
Beijing GoBroad Hospital
Mayo Clinic
Novartis
Beijing GoBroad Hospital
AIDS Malignancy Consortium
Step Pharma, SAS
M.D. Anderson Cancer Center
Essen Biotech
Kyowa Kirin Co., Ltd.
Memorial Sloan Kettering Cancer Center
University of Nebraska
Myeloid Therapeutics
Samsung Medical Center
Columbia University
Rhizen Pharmaceuticals SA
Alexion Pharmaceuticals, Inc.
University of Virginia
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Fred Hutchinson Cancer Center
Acrotech Biopharma Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Peking Union Medical College Hospital
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Samsung Medical Center
Mundipharma Research Limited